22 results
2 Percent MACE Image - After calculating the risk for acute coronary syndrome, select the corresponding
acute coronary syndrome ... #Management #PatientInfo ... #Cardiology #ChestPain
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
ISCHEMIA Trial - Management ... acute coronary syndrome ... Stable #Angina #ChestPain ... #Diagnosis #Management ... #Algorithm #Cardiology
1 Percent MACE Image - After calculating the risk for acute coronary syndrome, select the corresponding
acute coronary syndrome ... #Management #PatientInfo ... #Cardiology #ChestPain
3 Percent MACE Image - After calculating the risk for acute coronary syndrome, select the corresponding
acute coronary syndrome ... #Management #PatientInfo ... #Cardiology #ChestPain
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
CD4 count <100 cells ... CD4 count >100 cells ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
HEART Score – A Tool For the ED The HEART score is an excellent tool that
Acute Coronary Syndrome ... #Diagnosis #Management ... #Cardiology #HEART ... Stratification #ChestPain
LUMBAR Syndrome

What do you call a segmental lumbosacral hemangioma + spinal problems?? LUMBAR syndrome, a fairly
LUMBAR Syndrome ... LUMBAR syndrome, ... ensure correct management ... + MRI/MRA abd/pelvis ... #Radiology #Diagnosis
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Treating Isospora belli ... Infection General Management ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
CD4 count <200 cells ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
-6 activates T cells ... Cytokine Activation Syndrome ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications